IPOs, Initial Public Offerings: pre & post IPO

Summary: 10 IPOs Scheduled for the week of October 8th

Print this entry

Two scheduled to trade Wednesday, October 10

Ambarella (AMBA)
Based in Santa Clara, CA, Ambarella (AMBA) scheduled a $60 million IPO with a market capitalization of $259 million at a price range mid-point of $10 for Wednesday, October 10, 2012.

AMBA’s fables semiconductor business is not very predictable (pocket video products, for example, were big in 2011 and now account for only 1% of revenue), and AMBA has very little actual ‘branding’.

Amira Nature Foods (ANFI)
Based in United, the UAE, Amira Nature Foods (ANFI) scheduled a $126 million IPO with a market capitalization of $470 million at a price range mid-point of $14, for Wednesday, October 10, 2012.

The operating company is Amira India, which is two levels removed from the public, British Virgin Island registered company, ANFI.  This is the same structure employed by Chinese companies, which is why there are fewer Chinese IPOs in the U.S.

Five IPOS  scheduled to trade Thursday, October 11

Realogy Holdings  (RLGY)
Based in Parsippany, NJ, Realogy Holdings  (RLGY), sponsored by Apollo Global Mgt,  scheduled a $1 billion IPO with a market capitalization of $3.5 billion at a price range mid-point of $25, for Thursday, October 11, 2012.

There’s no demonstrated record of success RGLS can sell to investors.  Instead, RLGY/Apollo’s pitch is that there will be lots of future free cash flow generated that will be sheltered by the NOL to pay down the (huge) debt.

Shutterstock (SSTK)
Based in New York, NY, Shutterstock (SSTK) scheduled a $63 million IPO with a market capitalization of $459 million at a price range mid-point of $14 for Thursday, October 11, 2012.

SSTK has acquired and is continuing to acquire digital images, which it makes available on a subscription and an on-demand basis.  SSTK’s revenue stream is predictable and growing, and SSTK generates positive cash flow

Garrison Capital (GARS)
New York, NY, Garrison Capital (GARS) scheduled an $80 million IPO with a market capitalization of $254 million at a price range mid-point of $16, for Thursday, October 11. 2012.

GARS is a Business Development Corp (BDC) treated as a Regulated Investment Company (RIC).  GARS expects to pay a annualized dividend rate of 7.75% of the price range mid-point of $16.

Intercept Pharmaceuticals (ICPT)
Based in New York, NY, Intercept Pharmaceuticals (ICPT) scheduled a $60 million IPO with a market capitalization of $210 million at a price range mid-point of $14, for Thursday, October 11, 2012.

ICPT is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease.  ICPT is in Phase 3 clinical trials.

KYTHERA Biopharmaceuticals (KYTH)
Based in Calabasas, CA, KYTHERA Biopharmaceuticals (KYTH) scheduled a $60 million IPO with a market capitalization of $255 million at a price range mid-point of $15, for Thursday, October 11, 2012.

KYTH is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.  Venture-funded KYTH has established a major partnership with Bayer (BAYRY.PK) that has resulted in significant milestone payments.

Two IPOS  scheduled to trade Friday, October 12

Workday (WDAY)
Based in Pleasanton, CA, Workday (WDAY) scheduled a $513 million IPO with a market capitalization of $3.6 million at a price range mid-point of $22.50, for Friday, October 12, 2012.

WDAY provides cloud-based corporate solutions by functional area.  Primary competitors include Oracle (ORCL) and SAP AG (SAP), both of whom expanding their traditional on-premise enterprise applications with cloud-based applications, either through acquisition or in-house development

Diamondback Energy (FANG)
Based in Midland, TX, Diamondback Energy (FANG) scheduled a $225 million IPO with a market capitalization of $632 million at a price range mid-point of $18, for Friday, October 12, 2012.

FANG is an independent oil and natural gas company currently focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas

There is a wide swing in gain (loss) on derivative contracts:  +$5 million in 2011, -$13 million for the first six months of 2012.  Wide swings in derivative contracts creates significant earnings uncertainty.

One holdover
GlobeImmune (GBIM
)
Based in Louisville, CO, GlobeImmune (GBIM) originally scheduled a $60 million IPO with a market capitalization of $206 million at a price range mid-point of $12 for Thursday, September 20, 2012.   GBIM is day-to-day on this week’s IPO calendar.  It’s not good to be day-to-day.

NOT AN IPO
Linn Co LLC (LNCO)

This is a secondary packaged as an IPO for Linn Energy, LLC (LINE) to raise money without giving up voting rights.  It is not an true IPO.  LINE has a market capitalization of $8.38 billion and the IPO ‘price’ is to be based on (the same as or with a slight discount to) the price of LINE stock.

 

Post a Comment

 

Login

Lost your password?